In the last few years, there has been increasing interest in using blood samples to measure DNA methylation in cancer studies, with the most robust candidate genes ATM and BRCA1 showing associations between breast cancer risk and methylation changes [58,59]. The gene discussed is BRCA1; the disease is breast cancer.